Thailand on Friday delayed using the AstraZeneca made coronavirus vaccine as a precautionary measure after 9 European nations, together with Iceland, Denmark, Norway, Bulgaria, Estonia and Latvia, briefly suspended the jabs over blood clot considerations.
The delay was based mostly on the choice made by Denmark, Austria and others as a precaution, mentioned the Thai well being officers.
Austria whereas investigating loss of life from coagulation problems has stopped utilizing a batch of AstraZeneca pictures.
The opposite specialists, nonetheless, acknowledged there have been no reported instances of the vaccine inflicting blood clots or associated issues elsewhere, together with in Britain.
Yong Poovorawan, an advisor to Thailand’s vaccination program, mentioned the delay, pending an investigation into the reason for the reported aspect impact, won’t have a big effect on the rollout, the Related Press (AP) reported.
Earlier on Thursday, the European Medicines Company mentioned that there was no indication of the jab inflicting blood clots and added its advantages proceed to outweigh its dangers.
Aiming to inject 10 million doses a month from June, Thailand plans to cowl no less than half its inhabitants by the top of 2021.
Thailand started its vaccination drive earlier in February with an preliminary 200,000 doses of China’s Sinovac and 117,000 doses of AstraZeneca.